Patients with severe symptomatic aortic stenosis have a poor prognosis with medical
management alone, and balloon aortic valvuloplasty has failed to provide durable clinical …

The first human transcatheter aortic valve implantation (TAVI) in 2002, and several
subsequent single-center series, showed the feasibility of this new approach for the …

The development of transcatheter aortic valve implantation (TAVI) by our group has been a
20-year odyssey. In 1993, postmortem studies validated the concept of intravalvular stenting …

Background Transcatheter aortic valve implantation (TAVI) has been adopted worldwide as
the standard treatment for severe aortic stenosis in symptomatic patients at prohibitive or …

Since the first clinical implantation in 2002, transcatheter aortic valve implantation or
transcatheter aortic valve replacement (TAVR) has become an established therapy in the …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

In the early 1990s, the idea of Transcatheter Aortic Valve Implantation (TAVI) emerged from
clinicians by the insight that the long-term hemodynamic and clinical results of aortic balloon …

Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation
(TAVI) has emerged as an attractive treatment strategy for the treatment of patients with …

Transcatheter aortic valve implantation (TAVI) is becoming a reality in the management of
patients with severe aortic stenosis and high or prohibitive risk for standard surgical …

Background: Transcatheter aortic valve implantation (TAVI) is a rapidly evolving strategy for
therapy of aortic stenosis. We describe the effect of the learning curve from the first 270 high …